fr   en
Agreements
Select a partner :
Type of agreement :





Select a compound/Disease :
Choose date:
[<<]      «      51   |   52   |   53   |   54   |   55   |   56   |   57   |   58   |   59   |   60   |   61      »      [65]
Date Partners Compound / Disease area / Development phase Type of agreement Nature / Financial terms
2007-05-09 NovaTherea (GB)/Gamida Cell (Israel)
 
cell therapy products / lung diseases R&D
See details
2007-05-07 Affitech (Norway)
Roche (Switzerland)
human monoclonal antibodies / cancer R&D
licensing
See details
2007-05-07 RESprotect (Germany)/SciClone Pharmaceuticals (USA)
 
RP101 (nucleoside analogue - apoptosis inducer) / cancer licensing
See details
2007-05-02 Bachem (Switzerland)
immatics (Germany)
peptides / cancer manufacturing
See details
2007-05-02 Cancer Research Technology (GB)/Peptech (Australia)
 
therapeutic antibodies against antigens overexpressed by certain tumours, including SC101 and SC104 for colorectal cancer / cancer licensing
See details
2007-04-27 Crucell (The Netherlands)
Novartis (Switzerland)
PER.C6® technology /   licensing
See details
2007-04-25 Cytos Biotechnology (Switzerland)
Novartis (Switzerland)
CYT002-NicQb (therapeutic vaccine) / nicotine dependence manufacturing
commercialization/ distribution
development
See details
2007-04-19 Galapagos (Belgium)
AstraZeneca (GB)
service delivery in R&D (medicinal chemistry, combinatorial chemistry, toxicological testing, etc.) /   other
See details
2007-04-19 BTG (GB)/Novacea (USA)
 
AQ4N (banoxantrone) / cancer manufacturing
commercialization/ distribution
development
See details
2007-04-19 ProBioGen (Germany)/Minapharm (Egypt)
 
undisclosed therapeutic proteins /   manufacturing
commercialization/ distribution
development
See details
2007-04-19 Antisoma (GB)
Novartis (Switzerland)
AS1404 (now ASA404 - vascular disrupting agent) / several indications target in oncology: non-small-cell lung cancer, prostate cancer, ovarian cancer licensing
See details
2007-04-17 Vivalis (France)
Geovax (USA)
EBx® cell lines for production of the production of Geovax's MVA based HIV/AIDS vaccine licensing
See details
2007-04-16 Galapagos (Belgium)
Ono Pharmaceutical (Japan)
service delivery in R&D (screening, provision of compound libraries, medicinal chemistry, combinatorial chemistry, etc.). /   other
See details
2007-04-11 Transgene (France)
Roche (Switzerland)
therapeutic vaccines (including TG 4001) against diseases caused by the human papillomavirus. / diseases caused by the human papillomavirus (HPV) commercialization/ distribution
development
See details
2007-04-03 Crucell (The Netherlands)/Talecris Biotherapeutics (USA)
 
Prolastin® (an alpha-1 proteinase inhibitor) / emphysema in antitrypsin alpha-1-deficient patients commercialization/ distribution
See details
[<<]      «      51   |   52   |   53   |   54   |   55   |   56   |   57   |   58   |   59   |   60   |   61      »      [65]